We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sam Schulman

Sam Schulman MD, PhD

Professor of Medicine, Thrombosis Service, Master Clinic, HHS - General Hospital, Hamilton, Ontario, Canada

Sam Schulman graduated from Karolinska Institutet, Stockholm, Sweden in 1977 and became a specialist in Internal Medicine in 1984, with subspecialties in Hematology and in Coagulation in 1985. That year he also received his Dr Med Sc with the thesis: "Studies on the Medical Treatment of Deep Vein Thrombosis". He has worked within the field of coagulation disorders continuously since 1984 and was director of the Hemophilia Treatment Center in Stockholm 1996 to 2004. His major research activities have been clinical studies in venous thromboembolism, including several randomized trials, and in hemophilia and its complications. He is currently involved in trials with new antithrombotic agents, such as the oral thrombin inhibitors.

Sam Schulman has been a member of the Executive Committee of the World Federation of Hemophilia (2000-2004) and was chairman of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of ISTH 2005-2008. He was President for the XXV ISTH Congress in Toronto, 2015. He is a member of the ISTH Council since 2013. Dr. Schulman is Associate Professor in Internal Medicine at Karolinska Institute and since September 2004 also Professor in Medicine at McMaster University. He is Director of the Thrombosis Service at HHS-General Hospital in Hamilton since 2004 and was Director of the Clinical Thromboembolism Program of McMaster University 2007-2018. Moreover, he is professor at the Department of Obstetrics and Gynaecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

Sam Schulman has published over 230 original articles, 130 review articles or book chapters and is co-editor of the most recent, 6th, edition of the textbook Haemostasis and Thrombosis – Basic Principles and Clinical Practice.

Disclosures

Dr. Schulman receives research grants from Octapharma and Boehringer-Ingelheim and honoraria from Alnylam, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo and Sanofi.